AEON Biopharma Inc. - Ordinary Shares - Class A

XASE:AEON   4:00:00 PM EDT
0.95
+0.04 (+4.31%)
7:57:30 PM EDT: $0.97 +0.02 (+2.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

AEON Biopharma Inc. - Ordinary Shares - Class A Stock, XASE:AEON

5 Park Plaza, Suite 1750, Irvine, California 92614
United States of America
Phone: +1.949.354.6499
Number of Employees: 10

Description

AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.